Teladoc reported a 145% increase in quarterly revenue as more people booked virtual doctor visits during the pandemic. The stock was one of the big pandemic winners, though shares have given up some of those gains recently and were lower ahead of Thursday’s open. Teladoc CEO Jason Gorevic joined CNBC’s Bertha Coombs on “Squawk Box” to discuss the company’s results and forecast for 2021. To see the full interview with Gorevic sign up for a free trial to CNBC Pro: https://cnb.cx/2ZPZyd3
The telemedicine company’s shares dropped 6.6% after Teladoc released mixed quarterly results. The company posted a loss per share of 27 cents on revenue of $383.3 million. That loss was 3 cents per share higher than what analysts expected, according to Refinitiv. However, Teladoc’s revenue of $383.3 million beat a forecast of $378.9 million.
Turn to CNBC TV for the latest stock market news and analysis. From market futures to live price updates CNBC is the leader in business news worldwide.
The News with Shepard Smith is CNBC’s daily news podcast providing deep, non-partisan coverage and perspective on the day’s most important stories. Available to listen by 8:30pm ET / 5:30pm PT daily beginning September 30: https://www.cnbc.com/2020/09/29/the-news-with-shepard-smith-podcast.html?__source=youtube%7Cshepsmith%7Cpodcast
Connect with CNBC News Online
Get the latest news: http://www.cnbc.com/
Follow CNBC on LinkedIn: https://cnb.cx/LinkedInCNBC
Follow CNBC News on Facebook: https://cnb.cx/LikeCNBC
Follow CNBC News on Twitter: https://cnb.cx/FollowCNBC
Follow CNBC News on Instagram: https://cnb.cx/InstagramCNBC